KELUN PHARMA
00242242.790.58% ( -0.25 )
KELUN PHARMA (002422)
Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, produces, and sells infusion and non-infusion pharmaceutical products in China and internationally....
- Open
- 42.72
- High
- 43.30
- Low
- 41.35
- Prev. Close
- 43.04
- Volume
- 360.69K
- Turnover
- 1.53B
- Avg Price
- 42.44
- Bid/Ask Ratio
- --
- Amplitude
- 4.53%
- 52wk High
- 52.78
- Volume Ratio
- 0.74
- Turnover Ratio
- 2.27%
KELUN PHARMA Analyst Rating
View MoreForecast & Rating
Jul 24, 2026Price forecast
¥46.548.75%
Forecast & RatingStrong buy
9analysts
- Strong buy88.89%
- Buy0.00%
- Hold0.00%
- Sell11.11%
- Strong sell0.00%
News
- PR Newswire · May 30 at 08:51 AM
Kelun-Biotech Presents Pivotal Phase II Data for Lunbotinib Fumarate (A400/EP0031) in RET Fusion-Positive NSCLC at 2026 ASCO
- PR Newswire · May 21 at 07:00 PM
Kelun-Biotech to Present Two Registrational Studies in the Oral Presentation Session on Non-Small Cell Lung Cancer at ASCO 2026
- 雷帝触网 · Apr 3 at 05:10 AM
Huilun Pharmaceutical rushes to the Hong Kong stock market: annual revenue of 690 million, net loss of 170 million, many family members of Dong Dalun hold shares
- AASTOCKS · Mar 25 at 03:29 AM
CITIC International raised the target price of KELUN PHARMA to 507.11 yuan, rating it as "Buy."
- AASTOCKS · Mar 24 at 11:15 PM
In "The Big Banks," Citigroup lowered the target price for KELUN PHARMA to 500.7 yuan with a rating of "Outperform the Market."
- prnewswire · Mar 23 at 09:32 PM
22:31 ETKELUN-BIOTECH ANNOUNCED 2025 ANNUAL RESULTS: MULTIPLE PRODUCTS SUCCESSFULLY LAUNCHED WITH TIERED PIPELINE READY FOR TAKE-OFF
